Verified email-pattern data for Adoram Therapeutics is currently limited. You can still use the company insights and contact sections below.
Adoram Therapeutics is an Swiss-based biotech startup focused on developing cutting-edge therapeutic assets. Our pipeline includes two differentiated preclinical-stage allosteric modulators, backed by compelling preclinical proof-of-concept (PoC) data from ex vivo human and in vivo mouse studies.
Asset 1 is a negative allosteric modulator of A2AR, a best-in-class immuno-enhancer with excellent potential for immunotherapy in solid tumors. This asset is poised to synergize with existing and emerging blockbuster therapies, including immune checkpoint blockade (ICB) monoclonal antibodies, to offer enhanced efficacy in cancer treatments.
Asset 2 is a first-in-class positive allosteric modulator of A2AR, with the potential to transform the treatment of various inflammatory, immunological, and metabolic diseases. This asset has wide-ranging therapeutic applications aimed at improving patient outcomes across multiple disease areas.
Our allosteric approach to drug development offers a safer, more targeted, and effective alternative to conventional 'orthosteric' small molecules. At Adoram Therapeutics, we are committed to developing the next generation of small molecule medicines that improve the lives of patients worldwide.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Grand Lancy, Grand Lancy 1212, Ch
- Industry
- Biotechnology Research
- Website
- https://adoram.ch/
- HQ
- Grand Lancy, Grand Lancy
Adoram Therapeutics Questions
Adoram Therapeutics's website is https://adoram.ch/
Adoram Therapeutics's LinkedIn profile is https://ch.linkedin.com/company/adoram
Adoram Therapeutics has
4 employees.
View email and phone details for 4
employees at Adoram Therapeutics.
Adoram Therapeutics's industry is
Biotechnology Research
Adoram Therapeutics's top competitors are
Atanis Biotech Ag,
Ex Vivo,
Clee Medical,
Allegria Therapeutics,
Dyneo Technologies Sa,
Bioalps - Swiss Health Valley,
Shape Biopharmaceuticals Inc.,
Eviive Ag,
Ymmunobio,
Illumicell Ai.
Adoram Therapeutics's categories are Biotechnology Research
Adoram Therapeutics's founding year is 2022
Explore related pages
Related company profiles:
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.